nodes	percent_of_prediction	percent_of_DWPC	metapath
Clotrimazole—ABCC3—Fluorouracil—skin cancer	0.106	0.118	CbGbCtD
Clotrimazole—CYP1A2—Imiquimod—skin cancer	0.0729	0.0809	CbGbCtD
Clotrimazole—CYP2C8—Vismodegib—skin cancer	0.0653	0.0724	CbGbCtD
Clotrimazole—CYP2C19—Vismodegib—skin cancer	0.0548	0.0607	CbGbCtD
Clotrimazole—CYP2E1—Dacarbazine—skin cancer	0.0529	0.0587	CbGbCtD
Clotrimazole—CYP2A6—Fluorouracil—skin cancer	0.047	0.0522	CbGbCtD
Clotrimazole—CYP2C9—Vismodegib—skin cancer	0.0455	0.0505	CbGbCtD
Clotrimazole—ABCB1—Vismodegib—skin cancer	0.0442	0.049	CbGbCtD
Clotrimazole—CYP1A2—Vemurafenib—skin cancer	0.0399	0.0443	CbGbCtD
Clotrimazole—CYP3A4—Imiquimod—skin cancer	0.0382	0.0424	CbGbCtD
Clotrimazole—CYP3A4—Temozolomide—skin cancer	0.0382	0.0424	CbGbCtD
Clotrimazole—ABCC2—Docetaxel—skin cancer	0.0368	0.0408	CbGbCtD
Clotrimazole—CYP2D6—Vemurafenib—skin cancer	0.0329	0.0365	CbGbCtD
Clotrimazole—CYP1A2—Dacarbazine—skin cancer	0.0306	0.034	CbGbCtD
Clotrimazole—CYP3A4—Vismodegib—skin cancer	0.0265	0.0294	CbGbCtD
Clotrimazole—CYP3A7—Docetaxel—skin cancer	0.0246	0.0272	CbGbCtD
Clotrimazole—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0246	0.0272	CbGbCtD
Clotrimazole—ABCB1—Dactinomycin—skin cancer	0.0232	0.0257	CbGbCtD
Clotrimazole—CYP2C8—Fluorouracil—skin cancer	0.0232	0.0257	CbGbCtD
Clotrimazole—CYP3A4—Vemurafenib—skin cancer	0.0209	0.0232	CbGbCtD
Clotrimazole—CYP1A2—Fluorouracil—skin cancer	0.0179	0.0199	CbGbCtD
Clotrimazole—CYP2C9—Fluorouracil—skin cancer	0.0162	0.0179	CbGbCtD
Clotrimazole—ABCB1—Docetaxel—skin cancer	0.012	0.0133	CbGbCtD
Clotrimazole—CYP3A4—Docetaxel—skin cancer	0.00718	0.00796	CbGbCtD
Clotrimazole—Localized exfoliation—Bleomycin—skin cancer	0.00695	0.0755	CcSEcCtD
Clotrimazole—Skin irritation—Fluorouracil—skin cancer	0.00336	0.0366	CcSEcCtD
Clotrimazole—Aspartate aminotransferase increased—Vismodegib—skin cancer	0.00327	0.0355	CcSEcCtD
Clotrimazole—Stinging—Imiquimod—skin cancer	0.00325	0.0353	CcSEcCtD
Clotrimazole—Skin exfoliation—Imiquimod—skin cancer	0.00252	0.0273	CcSEcCtD
Clotrimazole—Muscle spasms—Vismodegib—skin cancer	0.0021	0.0228	CcSEcCtD
Clotrimazole—Blister—Fluorouracil—skin cancer	0.00202	0.0219	CcSEcCtD
Clotrimazole—Cystitis noninfective—Bleomycin—skin cancer	0.00183	0.0199	CcSEcCtD
Clotrimazole—Cystitis—Bleomycin—skin cancer	0.00181	0.0196	CcSEcCtD
Clotrimazole—Stinging—Fluorouracil—skin cancer	0.0018	0.0195	CcSEcCtD
Clotrimazole—Skin exfoliation—Bleomycin—skin cancer	0.00179	0.0194	CcSEcCtD
Clotrimazole—Bladder pain—Bleomycin—skin cancer	0.00169	0.0184	CcSEcCtD
Clotrimazole—Redness—Docetaxel—skin cancer	0.00156	0.0169	CcSEcCtD
Clotrimazole—Pain—Vismodegib—skin cancer	0.00153	0.0166	CcSEcCtD
Clotrimazole—Burning sensation—Docetaxel—skin cancer	0.00151	0.0164	CcSEcCtD
Clotrimazole—Skin exfoliation—Temozolomide—skin cancer	0.00151	0.0164	CcSEcCtD
Clotrimazole—Abdominal pain—Vismodegib—skin cancer	0.00141	0.0153	CcSEcCtD
Clotrimazole—Erythema—Vemurafenib—skin cancer	0.00135	0.0147	CcSEcCtD
Clotrimazole—Haemoglobin—Imiquimod—skin cancer	0.00133	0.0145	CcSEcCtD
Clotrimazole—Haemorrhage—Imiquimod—skin cancer	0.00132	0.0144	CcSEcCtD
Clotrimazole—Liver function test abnormal—Dactinomycin—skin cancer	0.00117	0.0127	CcSEcCtD
Clotrimazole—Erythema—Imiquimod—skin cancer	0.00115	0.0125	CcSEcCtD
Clotrimazole—Aspartate aminotransferase increased—Dactinomycin—skin cancer	0.00114	0.0124	CcSEcCtD
Clotrimazole—Vomiting—Vismodegib—skin cancer	0.00113	0.0123	CcSEcCtD
Clotrimazole—Rash—Vismodegib—skin cancer	0.00112	0.0122	CcSEcCtD
Clotrimazole—Dermatitis—Vismodegib—skin cancer	0.00112	0.0122	CcSEcCtD
Clotrimazole—Dermatitis bullous—Fluorouracil—skin cancer	0.0011	0.012	CcSEcCtD
Clotrimazole—Nausea—Vismodegib—skin cancer	0.00106	0.0115	CcSEcCtD
Clotrimazole—Aspartate aminotransferase increased—Temozolomide—skin cancer	0.00103	0.0112	CcSEcCtD
Clotrimazole—Skin exfoliation—Docetaxel—skin cancer	0.001	0.0109	CcSEcCtD
Clotrimazole—Abdominal distension—Temozolomide—skin cancer	0.000997	0.0108	CcSEcCtD
Clotrimazole—Haemoglobin—Bleomycin—skin cancer	0.000945	0.0103	CcSEcCtD
Clotrimazole—Oedema—Imiquimod—skin cancer	0.00094	0.0102	CcSEcCtD
Clotrimazole—Haemorrhage—Bleomycin—skin cancer	0.00094	0.0102	CcSEcCtD
Clotrimazole—Pollakiuria—Temozolomide—skin cancer	0.000915	0.00994	CcSEcCtD
Clotrimazole—Erythema—Bleomycin—skin cancer	0.000818	0.00889	CcSEcCtD
Clotrimazole—Pain—Imiquimod—skin cancer	0.000804	0.00874	CcSEcCtD
Clotrimazole—Dermatitis bullous—Docetaxel—skin cancer	0.000797	0.00867	CcSEcCtD
Clotrimazole—Haemoglobin—Temozolomide—skin cancer	0.000797	0.00866	CcSEcCtD
Clotrimazole—Haemorrhage—Temozolomide—skin cancer	0.000793	0.00862	CcSEcCtD
Clotrimazole—Erythema—Dactinomycin—skin cancer	0.000763	0.00829	CcSEcCtD
Clotrimazole—Urticaria—Imiquimod—skin cancer	0.000747	0.00811	CcSEcCtD
Clotrimazole—Abdominal pain—Imiquimod—skin cancer	0.000743	0.00808	CcSEcCtD
Clotrimazole—Haemoglobin—Fluorouracil—skin cancer	0.000734	0.00798	CcSEcCtD
Clotrimazole—Haemorrhage—Fluorouracil—skin cancer	0.00073	0.00794	CcSEcCtD
Clotrimazole—Liver function test abnormal—Docetaxel—skin cancer	0.000704	0.00765	CcSEcCtD
Clotrimazole—Vomiting—Vemurafenib—skin cancer	0.000701	0.00762	CcSEcCtD
Clotrimazole—Rash—Vemurafenib—skin cancer	0.000695	0.00755	CcSEcCtD
Clotrimazole—Dermatitis—Vemurafenib—skin cancer	0.000694	0.00755	CcSEcCtD
Clotrimazole—Erythema—Temozolomide—skin cancer	0.00069	0.0075	CcSEcCtD
Clotrimazole—Cramp muscle—Docetaxel—skin cancer	0.000686	0.00746	CcSEcCtD
Clotrimazole—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000686	0.00746	CcSEcCtD
Clotrimazole—Oedema—Bleomycin—skin cancer	0.000668	0.00726	CcSEcCtD
Clotrimazole—Nausea—Vemurafenib—skin cancer	0.000655	0.00711	CcSEcCtD
Clotrimazole—Erythema—Fluorouracil—skin cancer	0.000636	0.00691	CcSEcCtD
Clotrimazole—Oedema—Dactinomycin—skin cancer	0.000623	0.00677	CcSEcCtD
Clotrimazole—Vomiting—Imiquimod—skin cancer	0.000598	0.00649	CcSEcCtD
Clotrimazole—Rash—Imiquimod—skin cancer	0.000593	0.00644	CcSEcCtD
Clotrimazole—Dermatitis—Imiquimod—skin cancer	0.000592	0.00643	CcSEcCtD
Clotrimazole—Pain—Bleomycin—skin cancer	0.000571	0.00621	CcSEcCtD
Clotrimazole—Oedema—Temozolomide—skin cancer	0.000563	0.00612	CcSEcCtD
Clotrimazole—Nausea—Imiquimod—skin cancer	0.000558	0.00607	CcSEcCtD
Clotrimazole—KCNN4—nipple—skin cancer	0.000558	0.0877	CbGeAlD
Clotrimazole—Pain—Dactinomycin—skin cancer	0.000533	0.00579	CcSEcCtD
Clotrimazole—Urticaria—Bleomycin—skin cancer	0.00053	0.00577	CcSEcCtD
Clotrimazole—Haemoglobin—Docetaxel—skin cancer	0.00053	0.00576	CcSEcCtD
Clotrimazole—Haemorrhage—Docetaxel—skin cancer	0.000527	0.00573	CcSEcCtD
Clotrimazole—Oedema—Fluorouracil—skin cancer	0.000519	0.00564	CcSEcCtD
Clotrimazole—Abdominal pain—Dactinomycin—skin cancer	0.000492	0.00535	CcSEcCtD
Clotrimazole—Pain—Temozolomide—skin cancer	0.000482	0.00523	CcSEcCtD
Clotrimazole—Erythema—Docetaxel—skin cancer	0.000459	0.00499	CcSEcCtD
Clotrimazole—Urticaria—Temozolomide—skin cancer	0.000447	0.00486	CcSEcCtD
Clotrimazole—Abdominal pain—Temozolomide—skin cancer	0.000445	0.00484	CcSEcCtD
Clotrimazole—Pain—Fluorouracil—skin cancer	0.000444	0.00482	CcSEcCtD
Clotrimazole—Muscle spasms—Docetaxel—skin cancer	0.000441	0.0048	CcSEcCtD
Clotrimazole—Vomiting—Bleomycin—skin cancer	0.000425	0.00461	CcSEcCtD
Clotrimazole—Rash—Bleomycin—skin cancer	0.000421	0.00458	CcSEcCtD
Clotrimazole—Dermatitis—Bleomycin—skin cancer	0.000421	0.00457	CcSEcCtD
Clotrimazole—Urticaria—Fluorouracil—skin cancer	0.000412	0.00448	CcSEcCtD
Clotrimazole—Nausea—Bleomycin—skin cancer	0.000397	0.00431	CcSEcCtD
Clotrimazole—Vomiting—Dactinomycin—skin cancer	0.000396	0.0043	CcSEcCtD
Clotrimazole—Rash—Dactinomycin—skin cancer	0.000393	0.00427	CcSEcCtD
Clotrimazole—KCNN4—epithelium—skin cancer	0.000375	0.059	CbGeAlD
Clotrimazole—Oedema—Docetaxel—skin cancer	0.000375	0.00407	CcSEcCtD
Clotrimazole—Nausea—Dactinomycin—skin cancer	0.00037	0.00402	CcSEcCtD
Clotrimazole—Vomiting—Temozolomide—skin cancer	0.000358	0.00389	CcSEcCtD
Clotrimazole—Rash—Temozolomide—skin cancer	0.000355	0.00386	CcSEcCtD
Clotrimazole—Dermatitis—Temozolomide—skin cancer	0.000355	0.00386	CcSEcCtD
Clotrimazole—Nausea—Temozolomide—skin cancer	0.000335	0.00364	CcSEcCtD
Clotrimazole—Vomiting—Fluorouracil—skin cancer	0.00033	0.00359	CcSEcCtD
Clotrimazole—CYP17A1—connective tissue—skin cancer	0.000328	0.0515	CbGeAlD
Clotrimazole—Rash—Fluorouracil—skin cancer	0.000327	0.00356	CcSEcCtD
Clotrimazole—Dermatitis—Fluorouracil—skin cancer	0.000327	0.00355	CcSEcCtD
Clotrimazole—Pain—Docetaxel—skin cancer	0.00032	0.00348	CcSEcCtD
Clotrimazole—Nausea—Fluorouracil—skin cancer	0.000308	0.00335	CcSEcCtD
Clotrimazole—CYP11A1—connective tissue—skin cancer	0.000305	0.0479	CbGeAlD
Clotrimazole—Abdominal pain—Docetaxel—skin cancer	0.000296	0.00322	CcSEcCtD
Clotrimazole—KCNN4—lymphoid tissue—skin cancer	0.000289	0.0455	CbGeAlD
Clotrimazole—KCNN4—female reproductive system—skin cancer	0.000279	0.0438	CbGeAlD
Clotrimazole—Vomiting—Docetaxel—skin cancer	0.000238	0.00259	CcSEcCtD
Clotrimazole—Rash—Docetaxel—skin cancer	0.000236	0.00257	CcSEcCtD
Clotrimazole—Dermatitis—Docetaxel—skin cancer	0.000236	0.00256	CcSEcCtD
Clotrimazole—KCNN4—head—skin cancer	0.000233	0.0366	CbGeAlD
Clotrimazole—CYP17A1—female reproductive system—skin cancer	0.000231	0.0363	CbGeAlD
Clotrimazole—Nausea—Docetaxel—skin cancer	0.000222	0.00242	CcSEcCtD
Clotrimazole—CYP11A1—female reproductive system—skin cancer	0.000215	0.0338	CbGeAlD
Clotrimazole—CYP19A1—connective tissue—skin cancer	0.000198	0.0311	CbGeAlD
Clotrimazole—CYP17A1—head—skin cancer	0.000193	0.0304	CbGeAlD
Clotrimazole—CYP1A2—nipple—skin cancer	0.000187	0.0294	CbGeAlD
Clotrimazole—CYP11A1—head—skin cancer	0.00018	0.0282	CbGeAlD
Clotrimazole—ABCC3—female reproductive system—skin cancer	0.000167	0.0262	CbGeAlD
Clotrimazole—KCNN4—lymph node—skin cancer	0.000163	0.0256	CbGeAlD
Clotrimazole—CYP19A1—female reproductive system—skin cancer	0.00014	0.022	CbGeAlD
Clotrimazole—ABCC3—head—skin cancer	0.000139	0.0219	CbGeAlD
Clotrimazole—CYP17A1—lymph node—skin cancer	0.000135	0.0213	CbGeAlD
Clotrimazole—ABCC2—female reproductive system—skin cancer	0.000133	0.021	CbGeAlD
Clotrimazole—ABCB1—blood vessel—skin cancer	0.000133	0.0208	CbGeAlD
Clotrimazole—CYP11A1—lymph node—skin cancer	0.000126	0.0198	CbGeAlD
Clotrimazole—CYP19A1—head—skin cancer	0.000117	0.0183	CbGeAlD
Clotrimazole—CYP2B6—skin of body—skin cancer	0.000115	0.0181	CbGeAlD
Clotrimazole—CYP2C8—female reproductive system—skin cancer	0.0001	0.0157	CbGeAlD
Clotrimazole—ABCC3—lymph node—skin cancer	9.76e-05	0.0153	CbGeAlD
Clotrimazole—CYP2B6—lymphoid tissue—skin cancer	9.3e-05	0.0146	CbGeAlD
Clotrimazole—CYP2B6—female reproductive system—skin cancer	8.97e-05	0.0141	CbGeAlD
Clotrimazole—CYP2C9—female reproductive system—skin cancer	8.88e-05	0.014	CbGeAlD
Clotrimazole—CYP2E1—lymphoid tissue—skin cancer	8.73e-05	0.0137	CbGeAlD
Clotrimazole—CYP2E1—female reproductive system—skin cancer	8.42e-05	0.0132	CbGeAlD
Clotrimazole—CYP19A1—lymph node—skin cancer	8.17e-05	0.0128	CbGeAlD
Clotrimazole—ABCC2—lymph node—skin cancer	7.8e-05	0.0123	CbGeAlD
Clotrimazole—CYP2B6—head—skin cancer	7.49e-05	0.0118	CbGeAlD
Clotrimazole—CYP2E1—head—skin cancer	7.03e-05	0.0111	CbGeAlD
Clotrimazole—CYP3A4—female reproductive system—skin cancer	6.77e-05	0.0106	CbGeAlD
Clotrimazole—CYP2D6—female reproductive system—skin cancer	6.67e-05	0.0105	CbGeAlD
Clotrimazole—ABCB1—epithelium—skin cancer	6.46e-05	0.0101	CbGeAlD
Clotrimazole—ABCB1—mammalian vulva—skin cancer	5.6e-05	0.0088	CbGeAlD
Clotrimazole—CYP2D6—head—skin cancer	5.57e-05	0.00875	CbGeAlD
Clotrimazole—ABCB1—lymphoid tissue—skin cancer	4.97e-05	0.00782	CbGeAlD
Clotrimazole—ABCB1—female reproductive system—skin cancer	4.8e-05	0.00754	CbGeAlD
Clotrimazole—ABCB1—head—skin cancer	4.01e-05	0.0063	CbGeAlD
Clotrimazole—ABCB1—lymph node—skin cancer	2.81e-05	0.00441	CbGeAlD
